Cipher Pharmaceuticals Statistics
Total Valuation
CPHRF has a market cap or net worth of $155.06 million. The enterprise value is $113.45 million.
| Market Cap | 155.06M |
| Enterprise Value | 113.45M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CPHRF has 24.02 million shares outstanding. The number of shares has decreased by -4.53% in one year.
| Shares Outstanding | 24.02M |
| Shares Change (YoY) | -4.53% |
| Shares Change (QoQ) | +1.70% |
| Owned by Insiders (%) | 44.51% |
| Owned by Institutions (%) | 1.12% |
| Float | 22.05M |
Valuation Ratios
The trailing PE ratio is 7.02 and the forward PE ratio is 11.88.
| PE Ratio | 7.02 |
| Forward PE | 11.88 |
| PS Ratio | 6.97 |
| Forward PS | 6.99 |
| PB Ratio | 1.81 |
| P/FCF Ratio | 11.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.49, with an EV/FCF ratio of 8.29.
| EV / Earnings | 5.01 |
| EV / Sales | 5.10 |
| EV / EBITDA | 9.49 |
| EV / EBIT | 10.52 |
| EV / FCF | 8.29 |
Financial Position
The company has a current ratio of 7.96, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.96 |
| Quick Ratio | 7.49 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.02 |
| Interest Coverage | -5.18 |
Financial Efficiency
Return on equity (ROE) is 26.50% and return on invested capital (ROIC) is 22.05%.
| Return on Equity (ROE) | 26.50% |
| Return on Assets (ROA) | 24.51% |
| Return on Capital (ROIC) | 22.05% |
| Revenue Per Employee | $3.71M |
| Profits Per Employee | $3.78M |
| Employee Count | 6 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.84 |
Taxes
| Income Tax | -9.84M |
| Effective Tax Rate | -76.77% |
Stock Price Statistics
The stock price has increased by +149.42% in the last 52 weeks. The beta is 1.05, so CPHRF's price volatility has been similar to the market average.
| Beta (1Y) | 1.05 |
| 52-Week Price Change | +149.42% |
| 50-Day Moving Average | 6.31 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 50.85 |
| Average Volume (30 Days) | 18,996 |
Short Selling Information
The latest short interest is 11,427, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 11,427 |
| Short Previous Month | 48,425 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 0.97 |
Income Statement
In the last 12 months, CPHRF had revenue of $22.25 million and earned $22.66 million in profits. Earnings per share was $0.92.
| Revenue | 22.25M |
| Gross Profit | 17.52M |
| Operating Income | 10.78M |
| Pretax Income | 13.03M |
| Net Income | 22.66M |
| EBITDA | 11.96M |
| EBIT | 10.78M |
| Earnings Per Share (EPS) | $0.92 |
Balance Sheet
The company has $41.94 million in cash and $322,667 in debt, giving a net cash position of $41.62 million or $1.73 per share.
| Cash & Cash Equivalents | 41.94M |
| Total Debt | 322,667 |
| Net Cash | 41.62M |
| Net Cash Per Share | $1.73 |
| Equity / Book Value | 85.51M |
| Book Value Per Share | 3.56 |
| Working Capital | 46.82M |
Cash Flow
In the last 12 months, operating cash flow was $13.83 million and capital expenditures -$152,613, giving a free cash flow of $13.68 million.
| Operating Cash Flow | 13.83M |
| Capital Expenditures | -152,613 |
| Free Cash Flow | 13.68M |
| FCF Per Share | $0.56 |
Margins
Gross margin is 78.71%, with operating and profit margins of 48.44% and 101.82%.
| Gross Margin | 78.71% |
| Operating Margin | 48.44% |
| Pretax Margin | 58.55% |
| Profit Margin | 101.82% |
| EBITDA Margin | 53.74% |
| EBIT Margin | 48.44% |
| FCF Margin | 61.46% |
Dividends & Yields
CPHRF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.53% |
| Shareholder Yield | 4.53% |
| Earnings Yield | 14.61% |
| FCF Yield | 8.82% |
Analyst Forecast
The average price target for CPHRF is $4.75, which is -26.47% lower than the current price. The consensus rating is "Buy".
| Price Target | $4.75 |
| Price Target Difference | -26.47% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPHRF has an Altman Z-Score of 15.69 and a Piotroski F-Score of 6.
| Altman Z-Score | 15.69 |
| Piotroski F-Score | 6 |